David Wright has resigned as chief executive officer of HRA Pharma after five and half years at the helm of the French company.
With his departure date set for 31 August 2022, Wright said the time had come for him to stand aside. “I am extremely proud of what the business has achieved and accomplished, which recently culminated in the successful sale to Perrigo
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?